Most Recent
VW can’t quash own expert’s dual-mode testimony
Volkswagen lost its bid Tuesday to exclude evidence from its own expert witness it claims has gone off script, an early blow to the car maker in the massive trial alleging it installed dual-mode software in diesel vehicles to cheat on emissions tests.
LCM to fund $100M class action over Gladstone Ports dredging
Litigation funder LCM said Monday it had agreed to finance a $100 million class action on behalf of fishing operators and seafood suppliers who claim they lost their livelihoods after dredging at Gladstone Port in southern Queensland.
Saputo in talks to sell milk plant to appease ACCC
Canadian dairy giant Saputo said Monday it is considering selling a milk plant in Victoria to smooth regulatory approval of its proposed $1.3 billion deal to buy Murray Goulburn.
Activ8me pays up for false ACCC endorsement
Teleco provider Activ8me has run afoul of the law by falsely claiming the ACCC gave its internet services the thumbs up, the consumer regulator said Monday.
Taronga Zoo faces court in trade mark battle
Sydney's iconic Taronga Zoo will bare its teeth in court Tuesday for the first hearing in its trade mark battle against the creators of Sydney Zoo, a wildlife reserve in Darling Harbour.
Game-changing ruling finds Spotless workers owed redundancy
Long-time employees of Spotless Services who were fired after a subsidiary lost a cleaning contract with a Sunshine Coast shopping centre were owed redundancy pay, the Federal Court has found in a precedential ruling.
Ex-Norton Rose partner can’t move mediation out of Sydney
A former Norton Rose employment partner in litigation with the firm over his firing has lost his bid to move next week's scheduled mediation out of Sydney.
AstraZeneca resolves Crestor patent spat with Generic Health
Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca's cholesterol drug Crestor, two-and-a-half years after the High Court of Australia found the patent obvious and invalid.
Reckitt Benckiser to feel pain of GSK’s costs in Nurofen case
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline's legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival's Panadol.
Drink, drugs & a dodgy investigation can’t save a coal miner’s job
Alcohol, anti-depressants and the common use of bad language at the Illawarra coal mine did not excuse a sacked miner's threatening and expletive-laced phone calls to colleagues, the full Fair Work Commission has found.